ESC Premium Access

Circulating biomarkers of myocardial fibrosis and cellular apoptosis in patients with atrial fibrillation and heart failure with preserved ejection fraction

Congress Presentation

About the speaker

Associate Professor Mikhail Dzeshka

Grodno State Medical University, Grodno (Belarus)
0 follower

9 more presentations in this session

Left ventricular stiffness assessed by diastolic wall strain predicts infrequent atrial fibrillation

Speaker: Doctor H. Kishima (Hyogo, JP)


Outcomes of heart failure with reduced ejection fraction (HFrEF) status post implantable cardioverter-defibrillator (ICD) presenting with HFrEF exacerbation with verses without atrial fibrillation(AF)

Speaker: Doctor H. Arshad (Newark, US)


The impact of elective cardioversion for atrial fibrillation in heart failure patients

Speaker: Doctor J. Graby (Bath, GB)


Spironolactone in patients with permanent atrial fibrillation, possible heart failure protective potential.

Speaker: Professor R. Dabrowski (Warsaw, PL)


MOODS: a novel risk score to identify patients with atrial fibrillation and sleep apnoea

Speaker: Doctor K. Kadhim (Adelaide, AU)


Access the full session

Poster Session 4 - Epidemiology of atrial fibrillation, miscellaneous

Speakers: Associate Professor M. Dzeshka, Doctor H. Kishima, Doctor H. Arshad, Doctor J. Graby, Professor R. Dabrowski...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb